RhythmAnalytics vs Viz AAA
AI Verdict
Choose RhythmAnalytics if…
Choose RhythmAnalytics if your clinical practice requires AI-powered, automated interpretation of single-lead ECG data to detect and classify a wide range of cardiac arrhythmias. This tool is ideal for enhancing clinical decision support when managing patients with continuous or intermittent ECG monitoring from various FDA-cleared devices, such as Holter monitors or wearable sensors.
View RhythmAnalytics →Choose Viz AAA if…
Choose Viz AAA if your institution needs to rapidly detect and triage suspected Abdominal Aortic Aneurysm (AAA) directly from CT angiography scans. This solution is best suited for accelerating critical care pathways by providing real-time alerts and facilitating immediate, coordinated communication among multidisciplinary teams for urgent treatment decisions.
View Viz AAA →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | RhythmAnalytics | Viz AAA |
|---|---|---|
| Pricing | Contact vendor | Enterprise (hospital/health system) |
| Deployment | Cloud-based API | Cloud-based, integrates with PACS and EHR systems. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz AAAViz AAA offers a more comprehensive and direct user experience for clinicians, including mobile access to imaging, real-time alerts, and an integrated communication platform within existing hospital workflows. RhythmAnalytics, while powerful, is primarily an API, meaning its direct usability for end-users depends on third-party integration.
Clinical Value
TieBoth tools demonstrate significant clinical value with strong FDA clearances and published validation data in their respective specialized domains. RhythmAnalytics offers high accuracy in broad ECG interpretation, while Viz AAA provides rapid and accurate detection and triage for a critical, time-sensitive condition like AAA, both leading to improved patient outcomes.
Pricing & Value
Viz AAAWhile both require contacting the vendor for specific pricing, Viz AAA provides more transparency by detailing its subscription model factors (algorithms used, population size). Crucially, Viz AAA explicitly confirms having a Business Associate Agreement (BAA) and offers access to comprehensive compliance documentation, which adds significant value and reduces risk for healthcare enterprises.
Enterprise Readiness
Viz AAAViz AAA clearly demonstrates superior enterprise readiness with an explicit Business Associate Agreement (BAA), robust security certifications (SOC 2 Type II, HIPAA, ISO), and direct integration into hospital workflows with a secure communication platform. RhythmAnalytics, while FDA-cleared and HIPAA compliant, lacks public confirmation of a BAA, which is a critical requirement for many healthcare organizations.
Innovation
Viz AAAViz AAA holds the distinction of being the first FDA-cleared AI solution for AAA detection and triage, pioneering a new standard for rapid intervention in a life-threatening condition. Its integrated approach to detection, triage, communication, and mobile access for care coordination demonstrates a broader innovative impact on clinical workflows.
Support & Docs
Viz AAAViz AAA offers clearly defined and accessible support channels, including 24/7 urgent phone support, in-app contact, a dedicated customer success team with various specialists, and a comprehensive knowledge base with documentation. While Biofourmis has a support team, the specific details and accessibility of support and documentation for RhythmAnalytics are less transparent.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | RhythmAnalytics | Viz AAA |
|---|---|---|
| Name | RhythmAnalytics | Viz AAA |
| Company | Biofourmis Singapore Pte. | Viz.ai |
| Description | FDA-cleared, AI-powered cloud-based software that provides automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support for healthcare professionals and integrators. | First FDA-cleared AI-powered solution by Viz.ai for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, designed to accelerate diagnosis and care coordination. |
| Primary Function | Automated interpretation of cardiac arrhythmias from single-lead ECG data | Detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans |
| Key Feature Example | Detection of over 15 types of cardiac arrhythmias (including AFib, ventricular arrhythmias, ectopic beats) | AI-powered automatic detection of suspected AAA from CTA scans |
Videos
Demos, reviews, and walkthroughs featuring RhythmAnalytics and Viz AAA.